Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
OM
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
finance.yahoo.comPOSITIVO
Here's Why You Should Retain DaVita Stock in Your Portfolio for Now
DaVita Inc. DVA has been gaining from strong execution across its Integrated Kidney Care ("IKC") platform, improving treatment volumes and investments in technology and clinical innovation. The optimism is driven by solid first-quarter 202…
Reasons to Retain Hims & Hers Stock in Your Portfolio for Now
Hims & Hers Health HIMS has entered the last quarter of 2026 with strong momentum from weight loss offerings, international expansion and AI-enabled care. However, gross margin pressure from changing business mix, regulatory uncertainty su…
Can Fresenius Medical's 5008X Rollout Drive the Next Growth Phase?
Fresenius Medical Care AG FMS is accelerating the U.S. rollout of its 5008X CAREsystem as it pushes high-volume hemodiafiltration, or HVHDF, into more clinics. The deployment adds a technology-led growth avenue across both services and pro…
Outset Medical (OM) Q2 2026 Earnings Call Transcript
Image source: The Motley Fool. DATE Thursday, Aug. 6, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Chair and Chief Executive Officer - Leslie Trigg Chief Financial Officer - Renee Gaeta Investor Relations - Tina Jacobson Full Conference Call Tra…
Osisko Metals (TSX:OM) Is Up 20.8% After Reporting Deepening 2026 Losses Has The Bull Case Changed?
Osisko Metals Incorporated reported second-quarter 2026 results showing a net loss of C$84.13 million, versus net income of C$0.796 million in the same period a year earlier, with basic and diluted loss per share from continuing operations…
Outset Medical, Inc. (OM) Reports Q2 Loss, Beats Revenue Estimates
Outset Medical, Inc. (OM) came out with a quarterly loss of $0.8 per share versus the Zacks Consensus Estimate of a loss of $0.63. This compares to a loss of $0.84 per share a year ago. These figures are adjusted for non-recurring items. T…
Outset Medical Reports Second Quarter 2026 Results
Outset Medical, Inc. SAN JOSE, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to improve clinical outcomes in dialysis with less cost and…
Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
SAN JOSE, Calif., July 02, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first of-its-kind technology to improve clinical outcomes in dialysis with less cost and complexity (the “Comp…
Top Biotech Gainers: CANF Climbs, RGNT Gears Up For Europe Launch, RNAZ, ELTX On Watch
(RTTNews) - Today's leading biotech gainers include Can-Fite, following an update from its pancreatic cancer study; SeaStar Medical, driven by improving quarter-over-quarter revenue for its flagship product; and Elicio, which has refined i…
Here’s Why Outset Medical (OM) Rebound Sharply After Last Quarter’s Selloff
Minot Light Capital Partners, an investment management company, released its “Capital Appreciation Fund" Q1 2026 Investor Letter. A copy of the letter can be downloaded here. The fund declined by 2.7% in the first quarter of 2026 due to a…
Image source: The Motley Fool. DATE Wednesday, February 11, 2026 at 5 p.m. ET CALL PARTICIPANTS Chief Executive Officer — Leslie Trigg Chief Financial Officer — Renee Gaeta Need a quote from a Motley Fool analyst? Email pr@fool.com Full Co…
Image source: The Motley Fool. Date Thursday, May 7, 2026 at 4:30 p.m. ET Call participants Chief Executive Officer — Leslie L. Trigg Chief Financial Officer — Renee M. Gaeta Chief Commercial Officer — Derek Elliott Need a quote from a Mot…
Outset Medical Names Derick Elliott as Executive Vice President of Commercial
Outset Medical, Inc. SAN JOSE, Calif., April 06, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to improve clinical outcomes in dialysis with less cost and…
Outset Medical Names Derick Elliott as Executive Vice President of Commercial
SAN JOSE, Calif., April 06, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to improve clinical outcomes in dialysis with less cost and complexity, today an…
Analyst Sentiment on Outset Medical (OM) Remains Strong Following Q4 Results
Outset Medical, Inc. (NASDAQ:OM) is one of the 7 most volatile stocks under $5 for day trading.Analyst Sentiment on Outset Medical (OM) Remains Strong Following Q4 Results On February 12, 2026, Outset Medical, Inc. (NASDAQ:OM) shares recei…
Outset Medical, Inc. Q4 2025 Earnings Call Summary
Outset Medical, Inc. Q4 2025 Earnings Call Summary - Moby Strategic Transformation and Market Positioning Achieved 2025 revenue growth of 5% by overcoming operational adversity and recapitalizing the business to fund the path to cash flow…
Outset Medical logo Key Points Outset posted 2025 revenue of $119.5 million (up 5%), materially expanded non‑GAAP gross margins and narrowed non‑GAAP net loss to $65.4 million, ended the quarter with $173 million in cash and cut operating…
Outset Medical Reports Fourth Quarter and Full Year 2025 Financial Results
SAN JOSE, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to improve clinical outcomes in dialysis with less cost and complexity, today reported fi…
Stifel Lowers Price Target on Outset Medical, Inc. (OM) to $8, Maintains Buy Rating
We recently published an article titled 11 High Growth Micro-cap Stocks to Buy. On January 7, Stifel analyst Rick Wise lowered the price target on Outset Medical, Inc. (NASDAQ:OM) to $8 from $14 while maintaining a Buy rating on the shares…
Quant snapshot: Manulife, KBC, Ambev lead strong buys as Ultragenyx, Atomera lag
[Weekly report and stack of papers.] designer491 Financials, information technology, and consumer discretionary are set to lead this week’s earnings calendar, with 372 companies scheduled to report. This week’s quant rankings highlight a c…
OM Stock Gains on FDA Clearance for Next-Gen Tablo Dialysis System
Outset Medical, Inc. OM recently announced that its next-generation Tablo hemodialysis system has received 510(k) clearance, marking a key regulatory milestone for the company. The clearance positions Tablo as the first dialysis system to…
Outset Medical to Report Fourth Quarter 2025 Financial Results on Wednesday, February 11, 2026
SAN JOSE, Calif., Jan. 26, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it…
Outset Medical (OM) Soars 22.2%: Is Further Upside Left in the Stock?
Outset Medical, Inc. OM shares ended the last trading session 22.2% higher at $5.57. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 9.1% gain ov…
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Outset Medical, Inc. - OM
NEW YORK, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Outset Medical, Inc. (“Outset Medical” or the “Company”) (NASDAQ: OM). Such investors are advised to contact Danielle Peyton at new…
New Research Demonstrates the Advantages of an Insourced Dialysis Service Line for Acute-Care Facilities Using Outset Medical’s Tablo® Hemodialysis System
SAN JOSE, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced new res…
Outset Medical to Report Third Quarter 2025 Financial Results on Monday, November 10, 2025
SAN JOSE, Calif., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it…
MANTRA And Inveniam Reveal Plans For Global CRE Derivatives: Could This Trigger OM Rally?
MANTRA and Inveniam have jointly raised the curtains on the brand new Inveniam Chain, during the Agentic Summit held in Abu Dhabi, UAE on 21 October 2025. Ok. But what is it exactly? Inveniam Chain specializes as a Layer-2 blockchain that…
Inveniam and Mantra unveil Inveniam Chain: A layer 2 blockchain for private real estate assets
ABU DHABI, United Arab Emirates and DUBAI, United Arab Emirates and NEW YORK, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Inveniam Capital Partners ("Inveniam"), a global leader in decentralized data infrastructure for private market assets, and MAN…
Why Analysts See the Essity Story Shifting Amid Strategic Moves and Sector Challenges
Essity's consensus analyst price target has shifted slightly lower, moving from SEK 285.25 to SEK 282.33, as new research underscores a mix of optimism and caution regarding the company's trajectory. Despite recent strategic moves into hig…
How the Narrative Around Ericsson Is Shifting Amid Analyst Caution and Industry Headwinds
Telefonaktiebolaget LM Ericsson has seen its consensus analyst price target shift only slightly, moving from SEK78.65 to SEK77.62. This minor adjustment reflects continued caution among analysts, given the broader uncertainty facing the Eu…
Le forage d’extension au projet Mines Gaspé d’Osisko recoupe 133,7 mètres à une teneur moyenne de 1,04 % Cu
MONTRÉAL, 18 sept. 2025 (GLOBE NEWSWIRE) -- Osisko Metals Incorporated (la « Société » ou « Métaux Osisko ») (TSX : OM; OTCQX : OMZNF; FRANKFURT : 0B51) a le plaisir d’annoncer de nouveaux résultats de forage pour le projet de cuivre Mines…
Osisko Gaspé Expansion Hole Intersects 133.7 Metres Averaging 1.04% Cu
MONTREAL, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Osisko Metals Incorporated (the “Company" or "OsiskoMetals") (TSX: OM; OTCQX:OMZNF; FRANKFURT:0B51) is pleased to announce new drill results from the Gaspé Copper Project, located in the Gaspé P…
Tempus (TEM) Stock Jumps 13.6%: Will It Continue to Soar?
Tempus AI TEM shares soared 13.6% in the last trading session to close at $88.78. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 12.3% gain over the past four…
TMX Group Equity Financing Statistics - August 2025
Toronto Stock Exchange, TSX Venture Exchange Toronto, Ontario--(Newsfile Corp. - September 9, 2025) - TMX Group today announced its financing activity on Toronto Stock Exchange (TSX) and TSX Venture Exchange (TSXV) for August 2025. TSX wel…
Did NP3 Fastigheter’s (OM:NP3) Green Bond Offering Signal a Shift in Sustainable Capital Allocation Strategy?
NP3 Fastigheter AB announced a SEK 402 million fixed-income offering, featuring floating rate senior unsecured green notes due December 2028, with a principal amount of SEK 400 million and a price of 100.5%. This green bond issuance showca…
Global Undervalued Small Caps With Insider Actions In September 2025
In recent weeks, global markets have experienced a mix of optimism and caution, with smaller-cap stocks showing resilience amid fluctuating interest rate expectations and weaker-than-anticipated U.S. labor market data. As investors navigat…